Abstract
Breast cancer is the most prevalent malignancy among women, occurring in approximately one in eight women in Western countries (1). The BRCA1 and BRCA2 genes contribute 5~10% in genetic breast cancer and women with these mutations have a 60~80% risk of developing breast cancer by the age of 70 (2). To reduce this risk, close surveillance for the earlier detection of breast cancer at the most favorable stage is necessary. The strategy for the surveillance of high-risk women should differ from that of the general population. Screening of high-risk women should begin at a younger age, and clinical breast examinations and annual mammography should begin at 25-35 years of age (3, 4). Findings of several studies indicate that contrast-enhanced MRI is useful for screening highrisk women (5, 6). In addition, the American Cancer INTRODUCTION
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of the Korean Society of Magnetic Resonance in Medicine
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
